Adam Zhao

CEO at Anlongbio

Presenter

Adam Zhao is Chief Executive Officer of Anlong Biopharmaceutical, a Beijing-based biotechnology company developing innovative siRNA therapeutics. He leads the company’s corporate strategy, business development, and global partnering activities. Anlong is advancing a portfolio of preclinical RNA interference programs addressing areas of significant unmet medical need and is actively seeking global out-licensing, co-development, and regional partnership opportunities with biopharmaceutical companies.